Iovance Biotherapeutics, Inc. IOVA Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Iovance Biotherapeutics, Inc.’s reported figures.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s enterprise value?
- Iovance Biotherapeutics, Inc. (IOVA) reported enterprise value of $1.3B in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s enterprise value changed year-over-year?
- Iovance Biotherapeutics, Inc.'s enterprise value increased by 33.2% year-over-year, from $972.88M to $1.3B.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Iovance Biotherapeutics, Inc.'s enterprise value has grown at a -32.3% compound annual growth rate (CAGR), from $6.82B to $969.09M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.